Advertisement
Advertisement

AGL

AGL logo

agilon health, inc.

96.58
USD
Sponsored
+3.85
+4.15%
Aug 21, 15:59 UTC -4
Closed
exchange

After-Market

97.25

+0.67
+0.69%

AGL Earnings Reports

Positive Surprise Ratio

AGL beat 7 of 22 last estimates.

32%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.45B
/
-$1.25
Implied change from Q2 26 (Revenue/ EPS)
-2.93%
/
-220.19%
Implied change from Q3 25 (Revenue/ EPS)
+1.09%
/
-81.48%

agilon health, inc. earnings per share and revenue

On Aug 05, 2026, AGL reported earnings of 1.04 USD per share (EPS) for Q2 26, beating the estimate of -0.10 USD, resulting in a 1101.93% surprise. Revenue reached 1.49 billion, compared to an expected 1.46 billion, with a 2.23% difference. The market reacted with a -19.49% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of -1.25 USD, with revenue projected to reach 1.45 billion USD, implying an decrease of -220.19% EPS, and decrease of -2.93% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Auna S.A.
Report Date
Aug 18, 2026 For Q2 26
Estimate
$0.87
Actual
$0.50
Surprise
-42.39%
logo
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.11
Actual
$0.10
Surprise
-16.11%
logo
Forward Industries, Inc. Common Stock
Report Date
Aug 12, 2026 For Q3 26
Estimate
$0.03
Actual
$0.00
Surprise
-100.00%
logo
Park Dental Partners, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.33
Actual
$0.66
Surprise
+96.08%
logo
Sera Prognostics, Inc. Class A Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.18
Surprise
-13.85%
logo
DocGo Inc. Common Stock
Report Date
Aug 17, 2026 For Q2 26
Estimate
-$0.06
Actual
$0.16
Surprise
+353.16%
logo
SRX Global Inc
Report Date
Aug 13, 2026 For Q3 26
Estimate
-
Actual
-$0.36
Surprise
-
logo
Lifeward Ltd. Ordinary Shares
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$1.36
Actual
-$1.46
Surprise
-6.82%
logo
NeuroOne Medical Technologies Corporation Common Stock
Report Date
Aug 13, 2026 For Q3 26
Estimate
-$0.22
Actual
-$0.28
Surprise
-26.70%
logo
SeaStar Medical Holding Corporation Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.97
Actual
-$0.91
Surprise
+7.11%
FAQ
For Q2 2026, agilon health, inc. reported EPS of $1.04, beating estimates by 1101.93%, and revenue of $1.49B, 2.23% above expectations.
The stock price moved down -19.49%, changed from $107.85 before the earnings release to $86.83 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 11 analysts, agilon health, inc. is expected to report EPS of -$1.25 and revenue of $1.45B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement